Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
3761por Uwamariya, Josée, Nshunguyabahizi, Marcel, Nshimyumuremyi, Jean Népomuscène, Mukesharurema, Gerardine, Ndayishimiye, Emmanuel, Kamali, Innocent, Ndahimana, Jean d’Amour, Hedt-Gauthier, Bethany, Cubaka, Vincent K., Barnhart, Dale A.“…Despite these challenges, youth have an optimistic view of the future with dreams of health, economic attainment, marriage, and children. CONCLUSION: Healthcare providers should empower caregivers to support HIV disclosure. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3762por van Kalsbeek, Rebecca J, Korevaar, Joke C, Rijken, Mieke, Haupt, Riccardo, Muraca, Monica, Kepák, Tomáš, Kepakova, Katerina, Blondeel, Anne, Boes, Stefan, Frederiksen, Line E, Essiaf, Samira, Winther, Jeanette F, Hermens, Rosella P M G, Kienesberger, Anita, Loonen, Jacqueline J, Michel, Gisela, Mulder, Renée L, O'Brien, Kylie B, van der Pal, Helena J H, Pluijm, Saskia M F, Roser, Katharina, Skinner, Roderick, Renard, Marleen, Uyttebroeck, Anne, Follin, Cecilia, Hjorth, Lars, Kremer, Leontien C M“…This paper describes the protocol of the prospective cohort study (Care Study) to evaluate the feasibility and the health economic, clinical and patient-reported outcomes of implementing PanCareFollowUp Care as usual care in four European countries. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3763“…The objectives are to assess the effect of CAH on delirium, audible upper airway secretions, pain and other symptoms, and overall survival, as well as the tolerability of CAH, and the health economic impact. METHODS AND ANALYSIS: The study is a cluster randomised trial, involving 80 sites/clusters (mainly hospices) and 1600 patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3764por Darlington, Meryl, Scarica, Raffaele, Chavez-Pacheco, Xyomara, Blamplain Segar, Laeticia, Durand-Zaleski, Isabelle“…Purpose: This systematic review of health economic evaluations identified interventions that are both cost and outcome reducing to procure a list of candidate decrementally cost-effective technologies. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3765por Warren, Hannah, Wagner, Thomas, Gorin, Michael A, Rowe, Steven, Holman, Beverley Fiona, Pencharz, Deborah, El-Sheikh, Soha, Barod, Ravi, Patki, Prasad, Mumtaz, Faiz, Bex, Axel, Kasivisvanathan, Veeru, Moore, Caroline M, Campain, Nicholas, Cartledge, Jon, Scarsbrook, Andrew, Hassan, Fahim, O'Brien, Tim S, Stewart, Grant D, Mendichovszky, Iosif, Dizdarevic, Sabina, Alanbuki, Ammar, Wildgoose, William H, Wah, Tze, Vindrola-Padros, Cecilia, Pizzo, Elena, Dehbi, Hakim-Moulay, Lorgelly, Paula, Gurusamy, Kurinchi, Emberton, Mark, Tran, Maxine G B“…Training materials for (99m)Tc-sestamibi SPECT/CT interpretation will be developed, assessed and optimised. Early health economic modelling using a decision analytic approach for different diagnostic strategies will be performed to understand the potential cost-effectiveness of (99m)Tc-sestamibi SPECT/CT. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3766por Donovan, Thomasina, Abell, Bridget, Fernando, Manasha, McPhail, Steven M., Carter, Hannah E.“…The reporting quality of included studies was assessed using the Consolidated Health Economic Evaluation Reporting Standards checklist. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3767por Bath, Michael F., Kohler, Katharina, Hobbs, Laura, Kuhn, Isla, Nabulyato, William M., Kwizera, Arthur, Walker, Laura E., Wilkins, Tom, Stubbs, Daniel, Halimah, Sara, Burnstein, Rowan, Kolias, Angelos G., Hutchinson, Peter, Clarkson, John, Bashford, Tom“…We will collect data on any morbidity outcomes, health-related quality of life measures, or health economic assessments reported. We predict a high heterogeneity in these outcomes used and will therefore keep inclusion criteria broad. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3768por Rossau, Henriette Knold, Nilsson, Ingrid Maria Susanne, Busck-Rasmussen, Marianne, Ekstrøm, Claus Thorn, Gadeberg, Anne Kristine, Hirani, Jonas Cuzulan, Strandberg-Larsen, Katrine, Villadsen, Sarah Fredsted“…A process evaluation will be completed to evaluate the implementation of the intervention; a realist evaluation will provide an understanding of the mechanisms of change characterising the intervention. Finally, a health economic evaluation will assess the cost-effectiveness and cost-utility of this complex intervention. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3769por Zhang, Wenyi, Wu, Yao, Wen, Bo, Zhang, Yongming, Wang, Yong, Yin, Wenwu, Sun, Shanhua, Wei, Xianyu, Sun, Hailong, Zhang, Zhijie, Li, Shanshan, Guo, Yuming“…We aimed to assess the effect of NPIs on the incidence of infectious diseases during the COVID-19 pandemic in 2020 and evaluate the health economic benefits related to the reduction in the incidence of infectious diseases. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3770“…OBJECTIVE: To develop a mapping algorithm that can be used to predict EQ-5D-5L health utility scores from FACT-H&N and obtain health utility parameters for Chinese patients with papillary thyroid carcinoma (PTC), which can be used for cost-utility analysis in health economic. METHODS: A total of 1,050 patients with PTC from a tertiary hospital in China were included, and they completed FACT-H&N and EQ-5D-5L. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3771“…Home vision testing is feasible and accurate, but its precision, acceptability, health economic impact and carbon impact require more attention.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3772“…The study focuses on diabetic medications for outpatients. This health economic evaluation used the cost per visit, and sensitivity analyses were conducted utilizing the cost per patient according to the prevalence of diabetes mellitus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3773por Bungey, George, Chang-Douglass, Stacey, Hsu, Ming-Ann, Cappelleri, Joseph C., Young, Pamela, Woolcott, John“…OBJECTIVE: To evaluate outcomes and costs of including tofacitinib in treatment strategies for PsA from a third-party U.S. payer perspective, using a health economic model. METHODS: A decision tree model was developed to evaluate treatment sequences (up to 4 lines of advanced PsA therapy) with or without tofacitinib. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3774por Khan, Y, Verhaghe, N, Devleeschauwer, B, Cavillot, L, Gadeyne, S, Pauwels, N, Van den Borre, L, De Smedt, D“…Future reviews should consider the longer-term impact of pandemics on delayed CV care and evaluate the long-term health and health-economic impact of the COVID-19 pandemic on delayed CV care. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3775por Elvidge, Jamie, Hopkin, Gareth, Narayanan, Nithin, Nicholls, David, Dawoud, Dalia“…Peer-reviewed studies reporting full health economic evaluations of tests or treatments in English were included. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3776por Booth, Neill, Jula, Antti, Aronen, Pasi, Kaila, Minna, Klaukka, Timo, Kukkonen-Harjula, Katriina, Reunanen, Antti, Rissanen, Pekka, Sintonen, Harri, Mäkelä, Marjukka“…Over the last decade, evidence-based care has emerged to complement other approaches to antihypertensive care, often without health economic assessment of its costs and effects. This study looks at the extent to which changes proposed by the 2002 Finnish evidence-based Current Care Guidelines concerning the prevention, diagnosis, and treatment of hypertension (the ACCG scenario) can be considered cost-effective when compared to modelled prior clinical practice (the PCP scenario). …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3777“…Other secondary measures include the SF 36 bodily pain subscale, the CORE OM, the WBQ-12 and the EQ5D. Health economic data will be collected and measures of therapeutic engagement will be used to compare patient's views of therapists and GPs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3778por Campbell, Jonathan D, Gries, Katharine S, Watanabe, Jonathan H, Ravelo, Arliene, Dmochowski, Roger R, Sullivan, Sean D“…A standardized measure of treatment success will be useful in clinical and health economic applications.…”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3779Publicado 2009“…The major endpoint of the study is the change in albumin excretion; secondary endpoints include markers of CVD, renal function, retinopathy, quality of life combined with assessment of compliance and potential health economic benefits. DISCUSSION: AdDIT will provide important data on the potential renal and cardiovascular protective effects of ACEI and Statins in high-risk adolescents. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
3780por Hoogendoorn, Martine, Feenstra, Talitha L, Hoogenveen, Rudolf T, Al, Maiwenn, Mölken, Maureen Rutten-van“…CONCLUSION: This study provides an estimate of the exacerbation frequency per GOLD stage, which can be used for health economic and modeling purposes.…”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto